Document is current
Any future updates will be listed below
-
Authors
Butler, Alexandra E. http://orcid.org/0000-0002-5762-3917
Al-Qaissi, Ahmed
Sathyapalan, Thozhukat
Atkin, Stephen L.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03102801 at ClinicalTrials.govDocuments that mention this clinical trial
Plasma heat shock protein response to euglycemia in type 2 diabetes
https://doi.org/10.1136/bmjdrc-2020-002057
Angiopoietin-1: an early biomarker of diabetic nephropathy?
https://doi.org/10.1186/s12967-021-03105-9
Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?
https://doi.org/10.2337/dc20-1115
Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia
https://doi.org/10.1136/bmjdrc-2021-002211
- License Information
-
More Information
Article History
Received: 1 October 2021
Accepted: 4 October 2021
First Online: 13 October 2021
Declarations
:
: The trial was approved by the North West-Greater Manchester East Research Ethics Committee (REC number: 16/NW/0518), registered at ExternalRef removed (NCT03102801) on 06/04/2017 and conducted according to the Declaration of Helsinki. All participants provided written informed consent.
: All authors gave their consent for publication.
: No authors have any conflict of interest or competing interests to declare.
